carbamazepine has been researched along with Autistic Disorder in 17 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Autistic Disorder: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We herein report a case of new-onset epileptic seizures induced by carbamazepine in an individual with autism spectrum disorders (ASD)." | 7.72 | Carbamazepine may trigger new-onset epileptic seizures in an individual with autism spectrum disorders: a case report. ( Hashioka, S; Maekawa, T; Monji, A; Yanagimoto, K; Yoshida, I, 2004) |
| " Oxcarbazepine and lamotrigine were associated with increased occurrence of autism." | 4.95 | Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. ( Cogo, E; D'Souza, J; Finkelstein, Y; Hemmelgarn, BR; Hutton, B; Kealey, R; MacDonald, H; Reynen, E; Rios, P; Soobiah, C; Straus, SE; Thavorn, K; Tricco, AC; Veroniki, AA; Yazdi, F, 2017) |
| " We differentiated and treated human SK-N-SH neuroblastoma cells with a mixture (fluoxetine, carbamazepine and venlafaxine) and valproate (used as a positive control to induce autism-associated profiles), followed by transcriptome analysis with RNA-Seq approach." | 3.83 | Psychoactive pharmaceuticals at environmental concentrations induce in vitro gene expression associated with neurological disorders. ( Kaushik, G; Thomas, MA; Xia, Y; Yang, L, 2016) |
| "We herein report a case of new-onset epileptic seizures induced by carbamazepine in an individual with autism spectrum disorders (ASD)." | 3.72 | Carbamazepine may trigger new-onset epileptic seizures in an individual with autism spectrum disorders: a case report. ( Hashioka, S; Maekawa, T; Monji, A; Yanagimoto, K; Yoshida, I, 2004) |
| "The carbamazepine studies were inconclusive." | 2.38 | Nonneuroleptic treatment of disruptive behavior in organic mental syndromes. ( Perry, PJ; Smith, DA, 1992) |
| "The association between autism spectrum disorders (ASD) and epilepsy has been extensively documented, and the estimated prevalence varies depending upon the selected population and the clinical characteristics." | 1.72 | Autism with Epilepsy: A Neuropsychopharmacology Update. ( Canitano, R; Palumbi, R; Scandurra, V, 2022) |
| "A majority of cases of idiopathic autism in children likely result from unknown environmental triggers in genetically susceptible individuals." | 1.46 | Dysregulation of autism-associated synaptic proteins by psychoactive pharmaceuticals at environmental concentrations. ( Kaushik, G; Pfau, JC; Thomas, MA; Xia, Y, 2017) |
| "Most cases of idiopathic autism spectrum disorder (ASD) likely result from unknown environmental triggers in genetically susceptible individuals." | 1.42 | Psychoactive pharmaceuticals as environmental contaminants may disrupt highly inter-connected nodes in an Autism-associated protein-protein interaction network. ( Aho, KA; Kaushik, G; Thomas, MA, 2015) |
| "Idiopathic autism, caused by genetic susceptibility interacting with unknown environmental triggers, has increased dramatically in the past 25 years." | 1.38 | Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism. ( Klaper, RD; Thomas, MA, 2012) |
| "The role of adiponectin in autism is still debatable." | 1.36 | Variations of plasma leptin and adiponectin levels in autistic patients. ( Auteri, A; Blardi, P; Ceccatelli, L; de Lalla, A; Hayek, J; Vanessa, G, 2010) |
| "Citalopram was the most preferred antidepressant and Carbamazepine, the most preferred mood stabilizer/antiepileptic." | 1.35 | Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey. ( Deb, S; Unwin, GL, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bjørk, MH | 1 |
| Zoega, H | 1 |
| Leinonen, MK | 1 |
| Cohen, JM | 1 |
| Dreier, JW | 1 |
| Furu, K | 1 |
| Gilhus, NE | 1 |
| Gissler, M | 1 |
| Hálfdánarson, Ó | 1 |
| Igland, J | 1 |
| Sun, Y | 1 |
| Tomson, T | 1 |
| Alvestad, S | 1 |
| Christensen, J | 1 |
| Canitano, R | 1 |
| Palumbi, R | 1 |
| Scandurra, V | 1 |
| Veroniki, AA | 1 |
| Rios, P | 1 |
| Cogo, E | 1 |
| Straus, SE | 1 |
| Finkelstein, Y | 1 |
| Kealey, R | 1 |
| Reynen, E | 1 |
| Soobiah, C | 1 |
| Thavorn, K | 1 |
| Hutton, B | 1 |
| Hemmelgarn, BR | 1 |
| Yazdi, F | 1 |
| D'Souza, J | 1 |
| MacDonald, H | 1 |
| Tricco, AC | 1 |
| Kaushik, G | 3 |
| Xia, Y | 2 |
| Pfau, JC | 1 |
| Thomas, MA | 4 |
| Aho, KA | 1 |
| Yang, L | 1 |
| Pedrini, M | 1 |
| Noguera, A | 1 |
| Vinent, J | 1 |
| Torra, M | 1 |
| Jiménez, R | 1 |
| Blardi, P | 1 |
| de Lalla, A | 1 |
| Ceccatelli, L | 1 |
| Vanessa, G | 1 |
| Auteri, A | 1 |
| Hayek, J | 1 |
| Klaper, RD | 1 |
| Miyajima, T | 1 |
| Kumada, T | 1 |
| Saito, K | 1 |
| Fujii, T | 1 |
| Renier, WO | 1 |
| Monji, A | 1 |
| Maekawa, T | 1 |
| Yanagimoto, K | 1 |
| Yoshida, I | 1 |
| Hashioka, S | 1 |
| Kapetanovic, S | 1 |
| Unwin, GL | 1 |
| Deb, S | 1 |
| Smith, DA | 1 |
| Perry, PJ | 1 |
| Wong, SE | 1 |
| Floyd, J | 1 |
| Innocent, AJ | 1 |
| Woolsey, JE | 1 |
| Philippart, M | 1 |
2 reviews available for carbamazepine and Autistic Disorder
| Article | Year |
|---|---|
Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.
Topics: Anticonvulsants; Autistic Disorder; Bayes Theorem; Breast Feeding; Carbamazepine; Child; Epilepsy; F | 2017 |
Nonneuroleptic treatment of disruptive behavior in organic mental syndromes.
Topics: Adrenergic beta-Antagonists; Antisocial Personality Disorder; Autistic Disorder; Carbamazepine; Deme | 1992 |
15 other studies available for carbamazepine and Autistic Disorder
| Article | Year |
|---|---|
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
Topics: Anticonvulsants; Autism Spectrum Disorder; Autistic Disorder; Carbamazepine; Child; Cohort Studies; | 2022 |
Autism with Epilepsy: A Neuropsychopharmacology Update.
Topics: Adolescent; Anticonvulsants; Autistic Disorder; Carbamazepine; Child; Epilepsy; Humans; Lamotrigine | 2022 |
Dysregulation of autism-associated synaptic proteins by psychoactive pharmaceuticals at environmental concentrations.
Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Brain; Carbamazepine; Environment; Female; Flu | 2017 |
Psychoactive pharmaceuticals as environmental contaminants may disrupt highly inter-connected nodes in an Autism-associated protein-protein interaction network.
Topics: Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Autistic Disorder; Brain; Carbam | 2015 |
Psychoactive pharmaceuticals at environmental concentrations induce in vitro gene expression associated with neurological disorders.
Topics: Animals; Autistic Disorder; Carbamazepine; Cell Line, Tumor; Environmental Pollutants; Fluoxetine; G | 2016 |
Acute oxcarbazepine overdose in an autistic boy.
Topics: Adolescent; Anticonvulsants; Autistic Disorder; Carbamazepine; Drug Overdose; Humans; Male; Oxcarbaz | 2009 |
Variations of plasma leptin and adiponectin levels in autistic patients.
Topics: Adiponectin; Adolescent; Analysis of Variance; Antimanic Agents; Autistic Disorder; Body Mass Index; | 2010 |
Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism.
Topics: Animals; Autistic Disorder; Carbamazepine; Cell Adhesion Molecules; Cyclohexanols; Cyprinidae; Fluox | 2012 |
Autism in siblings with autosomal dominant nocturnal frontal lobe epilepsy.
Topics: Adolescent; Anticonvulsants; Asperger Syndrome; Autistic Disorder; Carbamazepine; Child; Child Devel | 2013 |
Compulsive spitting as manifestation of temporal lobe epilepsy.
Topics: Adolescent; Anticonvulsants; Autistic Disorder; Carbamazepine; Child; Compulsive Behavior; Dominance | 2004 |
Carbamazepine may trigger new-onset epileptic seizures in an individual with autism spectrum disorders: a case report.
Topics: Adult; Anticonvulsants; Autistic Disorder; Carbamazepine; Electroencephalography; Epilepsy, Tonic-Cl | 2004 |
Oxcarbazepine in youths with autistic disorder and significant disruptive behaviors.
Topics: Adolescent; Adult; Anticonvulsants; Attention Deficit and Disruptive Behavior Disorders; Autistic Di | 2007 |
Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey.
Topics: Adult; Aggression; Antipsychotic Agents; Attitude of Health Personnel; Autistic Disorder; Carbamazep | 2008 |
Applying a DRO schedule and compliance training to reduce aggressive and self-injurious behavior in an autistic man: a case report.
Topics: Adult; Aggression; Autistic Disorder; Behavior Therapy; Carbamazepine; Combined Modality Therapy; Ha | 1991 |
Clinical recognition of Rett syndrome.
Topics: Adolescent; Autistic Disorder; Carbamazepine; Child; Child, Preschool; Diagnosis, Differential; Fema | 1986 |